Bio-Rad Labs Inc. A buy Royal Bank of Canada
Start price
04.08.23
/
50%
€363.40
Target price
04.08.24
€474.64
Performance (%)
-17.06%
End price
05.08.24
€301.40
Summary
This prediction ended on 05.08.24 with a price of €301.40. The prediction for Bio-Rad Labs Inc. A disappointed with a performance of -17.06%. Royal_Bank_of_Canada has a follow-up prediction for Bio-Rad Labs Inc. A where he still thinks Bio-Rad Labs Inc. A is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bio-Rad Labs Inc. A | 8.493% | 8.493% | -16.630% |
| iShares Core DAX® | 1.560% | 4.721% | 18.671% |
| iShares Nasdaq 100 | 0.517% | 1.171% | 23.619% |
| iShares Nikkei 225® | 1.730% | 6.073% | 16.253% |
| iShares S&P 500 | 1.482% | 1.218% | 23.290% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target raised by analysts at Royal Bank of Canada from $522.00 to $524.00. They now have an "outperform" rating on the stock.
Ratings data for BIO provided by MarketBeat
In the thread Trading Bio-Rad Labs Inc. A
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten
Current prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€445.58
16.02.25
16.02.25
-3.45%
30.08.24
30.08.24
Stopped prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€292.30
16.08.24
16.08.24
€364.63
16.08.25
16.08.25
2.19%
30.08.24
30.08.24
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€307.80
02.08.24
02.08.24
€367.36
02.08.25
02.08.25
-0.81%
30.08.24
30.08.24